  U.S. attaches importance to pharmaceutics development in Armenia November 16, 2010 - 14:12 AMT PanARMENIAN.Net - Armenia can be a good pharmaceutical country, as it has experienced chemists, technological base and favorable investment climate, according to USAID/Armenia Deputy Mission Director John Seong. “The U.S. attaches importance to development of pharmaceutics in Armenia. Local manufacture of medicine helps diversify the economy, create job opportunities and make high-quality medicine affordable for the population,” Mr. Seong said, adding that the legislation should be reformed and investments attracted to develop pharmaceutics in the country.   Top stories Yerevan has dismissed Turkey’s demand to shut down the Armenian nuclear power plant as “inappropriate”. Armenia will loan 2.9 billion drams to Nagorno Karabakh (Artsakh), according to a draft government decision. The Ministry of Ecology and Natural Resources of Azerbaijan has “strongly condemned” Armenia’s decision. Kerobyan has said that for the first time in the history of Armenia, the volume of foreign direct investments amounted to about $1 billion.   Partner news |  Latest news Czech-Armenian military cooperation discussed in Yerevan  A delegation led by the Director General for the Industrial Cooperation Division of the Ministry of Defence of the Czech Republic visited Armenia.U.S. welcomes efforts to define Armenia-Azerbaijan border The United States welcomes efforts to define the border between Armenia and Azerbaijan, says Vedant Patel.Biden honors resilience of Armenian people on April 24 U.S. President Joe Biden has issued a statement on the 109th anniversary of the Armenian Genocide.Ex-Karabakh leader moved to solitary confinement cell in Baku, his son says David Vardanyan is the son of former Karabakh leader Ruben Vardanyan who who is currently imprisoned in Azerbaijan. |
